Wockhardt's antibiotic for community-acquired bacterial pneumonia gets regulatory approval
Healthcare Radius|November 2024
Community-acquired pneumonia is the most common infection leading to hospitalization and deaths. Children and older adults are particularly vulnerable.
Wockhardt's antibiotic for community-acquired bacterial pneumonia gets regulatory approval

The Subject Expert Committee (SEC) of the Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has provided a favorable recommendation for Wockhardt's novel antibiotic MiqnafTM (nafithromycin) discovered and developed for the treatment of Community-Acquired Bacterial Pneumonia (CABP) in adults.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM HEALTHCARE RADIUSView all
Aster Volunteers & BAPS launch mobile medical units in Gujarat
Healthcare Radius

Aster Volunteers & BAPS launch mobile medical units in Gujarat

Aster and BAPS launch two mobile units in Gujarat to provide essential healthcare to underserved communities, enhancing medical accessibility for marginalized individuals.

time-read
2 mins  |
March 2025
UNION EDOCET 2025-26 - A BOOSTER SHOT OR JUST A BAND-AID FOR HEALTHCARE?
Healthcare Radius

UNION EDOCET 2025-26 - A BOOSTER SHOT OR JUST A BAND-AID FOR HEALTHCARE?

While steps like medical seat expansion and AI-based diagnostics show promise, gaps in R&D funding, preventive care, and private sector support remain.

time-read
4 mins  |
March 2025
INDIA'S DETERMINED FIGHT AGAINST TB: PREVALENCE AND URGENCY
Healthcare Radius

INDIA'S DETERMINED FIGHT AGAINST TB: PREVALENCE AND URGENCY

By adopting data-driven and technology-enabled strategies, India can lead the way in eliminating TB as a public health threat, setting a global benchmark for disease management.

time-read
6 mins  |
March 2025
Adani, Mayo Clinic to revolutionize healthcare with 1000-bed hospitals and medical colleges
Healthcare Radius

Adani, Mayo Clinic to revolutionize healthcare with 1000-bed hospitals and medical colleges

Adani Group, Mayo Clinic to establish healthcare campuses in India with 1,000-bed hospitals, medical colleges, and cutting-edge research facilities.

time-read
1 min  |
March 2025
AIIMS hosts advanced orthopedic workshop for surgeons
Healthcare Radius

AIIMS hosts advanced orthopedic workshop for surgeons

AIIMS & DAIS conducted a hands-on orthopedic cadaver workshop, enhancing surgeons' skills in arthroscopy and foot surgery.

time-read
1 min  |
March 2025
Indian med students gain global edge with HSU-Oxford collab
Healthcare Radius

Indian med students gain global edge with HSU-Oxford collab

HSU teams up with Oxford International Education Group to offer global healthcare management programs for Indian students.

time-read
1 min  |
March 2025
NUA raises Rs 35Cr to accelerate growth in India
Healthcare Radius

NUA raises Rs 35Cr to accelerate growth in India

The funds will fuel retail expansion and new product launches, aiming to reach Rs 150 Cr ARR next quarter.

time-read
1 min  |
March 2025
Food adulteration: How FSSAI is cracking down on unsafe food
Healthcare Radius

Food adulteration: How FSSAI is cracking down on unsafe food

Discover how the government and FSSAI are tackling food adulteration with strict regulations, food testing, and safety measures to protect consumers.

time-read
1 min  |
March 2025
GVHD treatment advances with new drug approval in India
Healthcare Radius

GVHD treatment advances with new drug approval in India

India approves a breakthrough treatment for chronic graft-versus-host disease (GVHD), offering new hope for patients.

time-read
1 min  |
March 2025
Mumbai's new 300-bed cancer center assures personalized, ai-powered treatment
Healthcare Radius

Mumbai's new 300-bed cancer center assures personalized, ai-powered treatment

The facility will generate a large number of employment possibilities for researchers, support personnel, and medical professionals.

time-read
1 min  |
March 2025